Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
about
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevanceAssociation of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulationOverexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemiaDeletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemiaHigh Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia.EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway.DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia.Retroviral insertional mutagenesis identifies the del(5q) genes, CXXC5, TIFAB and ETF1, as well as the Wnt pathway, as potential targets in del(5q) myeloid neoplasms.CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.Haploinsufficient loss of multiple 5q genes may fine-tune Wnt signaling in del(5q) therapy-related myeloid neoplasms.Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.Downregulation of ROS1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines.Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer.Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates.
P2860
Q26776393-E2BFB304-5402-40A4-BECC-F11832AAB8B8Q30490446-9A3DE518-F9F4-4679-8FC3-2D9C38193932Q35550103-81952E39-6906-41C3-998D-9C1AC3987479Q36771874-8EA7ABBF-384E-4B7C-BFBD-EC639D62C006Q37140487-7BA2AD50-81FD-4A3E-8CD5-167C26E6C018Q37510247-3CC1EB48-D8CA-4102-A519-9582725C2F4CQ37645063-E9C91067-366A-4399-AC2D-81E9A483DF61Q38699939-415D16B6-D76A-4565-8CA3-7BCA3E618827Q38773224-7553BA44-A06F-444F-B0B5-70622B16A69EQ38817863-5AD4E1A6-5E0C-4DE3-A912-777035937376Q40832501-4577B991-1571-42F2-9E26-8AC998FC8EBAQ42361215-1F3B310A-758D-4580-96C4-BDC80F6AE07EQ42366772-B786C476-E178-4D49-A89A-A44F8E3B3766Q42397482-FC425EF6-520A-410B-BCCD-103540931C0CQ42778168-BB17CE1C-4DB2-4142-988C-463B75C845C8Q43115423-A6313FF4-107E-45A6-A4FB-34B9BB0B9DFAQ49668289-539E8EB0-FC14-4113-A0A0-58B2A41E8643Q51102707-40EF594D-82D7-4150-A18A-7685D5922493Q54977738-DD3CDB15-F37F-4755-929F-E0959C7BA9BBQ55270272-EC960179-C985-4D13-8179-698C3AF95519Q55690016-EB182FCD-6FD6-492A-87BF-D9C264E89EEA
P2860
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Downregulation of the Wnt inhi ...... sis in acute myeloid leukemia.
@ast
Downregulation of the Wnt inhi ...... sis in acute myeloid leukemia.
@en
type
label
Downregulation of the Wnt inhi ...... sis in acute myeloid leukemia.
@ast
Downregulation of the Wnt inhi ...... sis in acute myeloid leukemia.
@en
prefLabel
Downregulation of the Wnt inhi ...... sis in acute myeloid leukemia.
@ast
Downregulation of the Wnt inhi ...... sis in acute myeloid leukemia.
@en
P2093
P2860
P50
P1433
P1476
Downregulation of the Wnt inhi ...... sis in acute myeloid leukemia.
@en
P2093
Alan K Burnett
Amanda Gilkes
Andrea Kühnl
Claudia D Baldus
David C Linch
David Grimwade
Ellen Solomon
Estelle Duprez
Ken I Mills
P2860
P304
P356
10.1182/BLOOD-2014-12-613703
P407
P577
2015-03-24T00:00:00Z